このページの翻訳は実験的なもので、現在開発中です。お待ちしております
NATCO Pharma マネジメント
マネジメント 基準チェック /14
NATCO Pharma'sの CEO はRajeev Nannapaneniで、 Jun2012年に任命され、 の在任期間は 12.17年です。 は、会社の株式の0.63%を直接所有しており、その価値は₹ 1.64B 。経営陣と取締役会の平均在任期間はそれぞれ7.5年と9.6年です。
主要情報
Rajeev Nannapaneni
最高経営責任者
₹98.7m
報酬総額
| CEO給与比率 | n/a |
| CEO在任期間 | 12.3yrs |
| CEOの所有権 | 0.6% |
| 経営陣の平均在職期間 | 7.6yrs |
| 取締役会の平均在任期間 | 2.1yrs |
経営陣の近況
Recent updates
NATCO Pharma Limited's (NSE:NATCOPHARM) Shares Bounce 26% But Its Business Still Trails The Market
Aug 13
If EPS Growth Is Important To You, NATCO Pharma (NSE:NATCOPHARM) Presents An Opportunity
Jul 15NATCO Pharma (NSE:NATCOPHARM) Seems To Use Debt Rather Sparingly
Jun 30NATCO Pharma Limited's (NSE:NATCOPHARM) Earnings Are Not Doing Enough For Some Investors
Jun 14NATCO Pharma Limited (NSE:NATCOPHARM) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models
May 30Calculating The Fair Value Of NATCO Pharma Limited (NSE:NATCOPHARM)
May 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Apr 03NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.25
Feb 21NATCO Pharma Limited Just Beat EPS By 223%: Here's What Analysts Think Will Happen Next
Feb 18NATCO Pharma Limited (NSE:NATCOPHARM) Surges 25% Yet Its Low P/E Is No Reason For Excitement
Feb 17Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jan 25An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 37% Undervalued
Jan 09Does NATCO Pharma (NSE:NATCOPHARM) Deserve A Spot On Your Watchlist?
Dec 13An Intrinsic Calculation For NATCO Pharma Limited (NSE:NATCOPHARM) Suggests It's 42% Undervalued
Sep 30Here's Why We Think NATCO Pharma (NSE:NATCOPHARM) Might Deserve Your Attention Today
Sep 12NATCO Pharma (NSE:NATCOPHARM) Is Paying Out A Larger Dividend Than Last Year
Aug 12Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
Jul 16NATCO Pharma Limited (NSE:NATCOPHARM) Shares Could Be 44% Below Their Intrinsic Value Estimate
Apr 20Is NATCO Pharma Limited (NSE:NATCOPHARM) Trading At A 46% Discount?
Dec 20NATCO Pharma's (NSE:NATCOPHARM) Upcoming Dividend Will Be Larger Than Last Year's
Aug 12Does NATCO Pharma (NSE:NATCOPHARM) Have A Healthy Balance Sheet?
Jun 23Broker Revenue Forecasts For NATCO Pharma Limited (NSE:NATCOPHARM) Are Surging Higher
Jun 02CEO（最高経営責任者
Rajeev Nannapaneni (47 yo)
12.3yrs
在職期間
₹98,670,000
報酬
Sri Rajeev Nannapaneni serves as Chief Executive Officer at NATCO Pharma Limited since April 1, 2022 and also served as Vice Chairman since June 1, 2012 until April 1, 2022 and serves as its Vice Chairman...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Chairman | 43yrs | ₹100.77m | 25.1% ₹ 63.8b | |
| CEO & Vice Chairman | 12.3yrs | ₹98.67m | 0.63% ₹ 1.6b | |
| Chief Financial Officer | 8.6yrs | ₹13.36m | データなし | |
| President of Technical Affairs & Whole Time Director | no data | ₹33.69m | 0.030% ₹ 76.9m | |
| Company Secretary & Compliance Officer | 2.4yrs | ₹2.61m | データなし | |
| Executive VP of Corporate Engineering Services & Whole Time Director | no data | ₹20.16m | 0.023% ₹ 58.4m | |
| Executive VP of Technical Operations & Director | 7.6yrs | ₹32.12m | 0.013% ₹ 33.1m | |
| VP & Head of Operations | no data | データなし | データなし | |
| Executive Vice President of Corporate Affairs | no data | データなし | データなし | |
| Vice President of Marketing & Sales - Domestic | less than a year | データなし | データなし | |
| Senior Vice President of HR & Organisational Development | no data | データなし | 0.0062% ₹ 15.8m | |
| Executive Vice President of R&D | 30.4yrs | データなし | 0.025% ₹ 62.6m |
7.6yrs
平均在職期間
65yo
平均年齢
経験豊富な経営陣: NATCOPHARMの経営陣は経験豊富で経験豊富です（平均在職期間は7.5年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| MD & Chairman | 43yrs | ₹100.77m | 25.1% ₹ 63.8b | |
| CEO & Vice Chairman | 18.8yrs | ₹98.67m | 0.63% ₹ 1.6b | |
| President of Technical Affairs & Whole Time Director | 9.6yrs | ₹33.69m | 0.030% ₹ 76.9m | |
| Executive VP of Corporate Engineering Services & Whole Time Director | 9.8yrs | ₹20.16m | 0.023% ₹ 58.4m | |
| Executive VP of Technical Operations & Director | 2.1yrs | ₹32.12m | 0.013% ₹ 33.1m | |
| Independent Director | 9.6yrs | ₹330.00k | データなし | |
| Independent Director | less than a year | データなし | データなし | |
| Independent Director | less than a year | データなし | データなし | |
| Independent Non-Executive Director | less than a year | データなし | データなし | |
| Independent Non-Executive Director | less than a year | データなし | データなし | |
| Independent Non-Executive Director | less than a year | データなし | データなし |
2.1yrs
平均在職期間
66yo
平均年齢
経験豊富なボード: NATCOPHARMの 取締役会 は 経験豊富 ではない ( 2.1年の平均在任期間) ため、新しい取締役会が必要であると考えられます。